Kiousi P - Search Results

1

Human in vivo metabolism study of LGD-4033.

Fragkaki AG, Sakellariou P, Kiousi P, Kioukia-Fougia N, Tsivou M, Petrou M, Angelis Y. Fragkaki AG, et al. Among authors: kiousi p. Drug Test Anal. 2018 Nov;10(11-12):1635-1645. doi: 10.1002/dta.2512. Epub 2018 Nov 8. Drug Test Anal. 2018. PMID: 30255601

2

Preventive doping control analysis: liquid and gas chromatography time-of-flight mass spectrometry for detection of designer steroids.

Georgakopoulos CG, Vonaparti A, Stamou M, Kiousi P, Lyris E, Angelis YS, Tsoupras G, Wuest B, Nielen MW, Panderi I, Koupparis M. Georgakopoulos CG, et al. Among authors: kiousi p. Rapid Commun Mass Spectrom. 2007;21(15):2439-46. doi: 10.1002/rcm.3103. Rapid Commun Mass Spectrom. 2007. PMID: 17610244

3

Two-step silylation procedure for the unified analysis of 190 doping control substances in human urine samples by GC-MS.

Kiousi P, Angelis YS, Lyris E, Koupparis M, Calokerinos AC, Atta-Politou J, Georgakopoulos CG. Kiousi P, et al. Bioanalysis. 2009 Oct;1(7):1209-24. doi: 10.4155/bio.09.113. Bioanalysis. 2009. PMID: 21083047

4

Examination of the kinetic isotopic effect to the acetylation derivatization for the gas chromatographic-combustion-isotope ratio mass spectrometric doping control analysis of endogenous steroids.

Angelis YS, Kioussi MK, Kiousi P, Brenna JT, Georgakopoulos CG. Angelis YS, et al. Among authors: kiousi p. Drug Test Anal. 2012 Dec;4(12):923-7. doi: 10.1002/dta.408. Epub 2012 Feb 28. Drug Test Anal. 2012. PMID: 22374794

5

A synopsis of the adverse analytical and atypical findings between 2005 and 2011 from the Doping Control Laboratory of Athens in Greece.

Kioukia-Fougia N, Fragkaki A, Kiousi P, Leontiou IP, Dimopoulou H, Tsivou M, Lyris E, Georgakopoulos C. Kioukia-Fougia N, et al. Among authors: kiousi p. J Anal Toxicol. 2014 Jan-Feb;38(1):16-23. doi: 10.1093/jat/bkt089. Epub 2013 Nov 4. J Anal Toxicol. 2014. PMID: 24194481

6

Comparison of sulfo-conjugated and gluco-conjugated urinary metabolites for detection of methenolone misuse in doping control by LC-HRMS, GC-MS and GC-HRMS.

Fragkaki AG, Angelis YS, Kiousi P, Georgakopoulos CG, Lyris E. Fragkaki AG, et al. Among authors: kiousi p. J Mass Spectrom. 2015 May;50(5):740-8. doi: 10.1002/jms.3583. J Mass Spectrom. 2015. PMID: 26259657

7

Current status and recent advantages in derivatization procedures in human doping control.

Athanasiadou I, Kiousi P, Kioukia-Fougia N, Lyris E, Angelis YS. Athanasiadou I, et al. Among authors: kiousi p. Bioanalysis. 2015 Oct;7(19):2537-56. doi: 10.4155/bio.15.172. Epub 2015 Oct 15. Bioanalysis. 2015. PMID: 26466807 Review.

8

Markers of mesterolone abuse in sulfate fraction for doping control in human urine.

Kiousi P, Angelis YS, Fragkaki AG, Abushareeda W, Alsayrafi M, Georgakopoulos C, Lyris E. Kiousi P, et al. J Mass Spectrom. 2015 Dec;50(12):1409-19. doi: 10.1002/jms.3715. J Mass Spectrom. 2015. PMID: 26634976

9

Challenges in detecting substances for equine anti-doping.

Fragkaki AG, Kioukia-Fougia N, Kiousi P, Kioussi M, Tsivou M. Fragkaki AG, et al. Among authors: kiousi p. Drug Test Anal. 2017 Sep;9(9):1291-1303. doi: 10.1002/dta.2162. Epub 2017 Apr 5. Drug Test Anal. 2017. PMID: 28087984 Review.

10

Human in vivo metabolism study of LGD-4033.

Fragkaki AG, Sakellariou P, Kiousi P, Kioukia-Fougia N, Tsivou M, Petrou M, Angelis Y. Fragkaki AG, et al. Among authors: kiousi p. Drug Test Anal. 2020 Jan;12(1):164. doi: 10.1002/dta.2700. Epub 2019 Nov 17. Drug Test Anal. 2020. PMID: 31984662 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

18 results

Search Page